FAP International Information Foundation
September 05, 2010, 08:23:32 PM *
Welcome, Guest. Please login or register.

Login with username, password and session length
News: Started FAP International Information Foundation
 
   FAP Web Home   Home   Help Search Calendar Login Register  
Pages: [1]
  Print  
Author Topic: Attitudes toward Prenatal Genetic Testing  (Read 199 times)
Brenda B
Sr. Member
****
Offline Offline

Gender: Female
Posts: 166



« on: August 15, 2009, 07:12:26 PM »
ReplyReply

Attitudes toward prenatal genetic testing in patients with familial adenomatous polyposis.
Kastrinos F, Stoffel EM, Balmańa J, Syngal S.
Division of Gastroenterology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA 02115, USA.

OBJECTIVES:
Familial adenomatous polyposis (FAP) is an autosomal dominant syndrome with >95% risk of colorectal cancer without prophylactic colectomy. Classic FAP is commonly associated with adenomatous polyposis coli (APC) gene mutations. If a mutation is identified, prenatal testing can reveal whether an embryo or fetus is affected. We conducted a pilot study to assess FAP patients' attitudes toward prenatal testing.

METHODS: Twenty individuals with FAP completed a 40-item survey on personal and family history related to FAP, demographics, and attitudes toward prenatal tests including amniocentesis, chorionic villous sampling (CVS), and preimplantation genetic diagnosis (PGD).

RESULTS: Thirteen women and seven men participated. Ninety-five percent (19/20) would consider undergoing prenatal testing for FAP: 90% would consider PGD, 75% would consider amniocentesis or CVS. Having an affected child and experiencing a first-degree relative's (FDR) death secondary to FAP were associated with greater willingness to consider prenatal testing. Personal history of cancer or FAP-associated tumors did not influence the decision to consider prenatal testing. One hundred percent said it was ethical to provide prenatal testing for FAP and four of five subjects who self-reported strong religious backgrounds would consider prenatal testing for FAP. Early reassurance of having an unaffected child was the most important advantage of PGD and avoiding pregnancy termination was important for 64% and 71% of women and men, respectively.

CONCLUSIONS: Patients with FAP are willing to consider prenatal testing to prevent transmission of disease to their children. Physicians caring for FAP patients should discuss available prenatal diagnostic options with patients of childbearing age.

Resource American Journal Gastroenterol. 2007 Jun;102(6):1284-90. Epub 2007 Mar 13



« Last Edit: August 15, 2009, 07:14:30 PM by Brenda B » Logged

1975 Total Colectomy; 1989 BCIR
Pages: [1]
  Print  
 
Jump to:  

Powered by MySQL Powered by PHP Powered by SMF 1.1.8 | SMF © 2006-2008, Simple Machines LLC Valid XHTML 1.0! Valid CSS!